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Aim: In this naturalistic study the aim was to examine the impact on seizure duration of stimulus intensity, previous 
treatments (during the first course of ECT), age, gender, and electrode placement. 
Method: The database of the ECT Service of the Royal Hobart Hospital was examined for the 15 years ending in 
2010. First courses of ECT were identified in which the stimulus intensity was not altered and at least 5 treatments 
were provided. Seizure duration was determined by cessation of clonic movements.  
Result: 383 patients (164 males) met selection criteria. A multiple regression analysis revealed that previous treat-
ments, age, gender, and electrode placement had non-significant regression coefficient on the seizure length. The stimulus 
intensity, however, showed significant regression coefficient (-.267, p <.001), indicating that higher stimulus intensity 
induced shorter seizure duration. 
Conclusion: It was suggested that electrode placement and the number of treatments had negligible influence on seizure 
duration, while high stimulus intensity reduced seizure duration. If fixed high dose ECT is being provided, and there 
is concern due to the brevity of seizures, rather than taking steps to increase the output of the machine, a modest reduc-
tion of dose (perhaps to < 428.4 mC, or < 85% of machine output) may increase seizure duration (German J Psy-
chiatry 2011; 14: 35–39).  
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arly work (Ottosson, 1963) suggested that for a 
seizure to have antidepressant effects, it needed to 
last longer than 25-30 seconds. This became a uni-
versal standard and a recommendation of the American 
Psychiatric Association Taskforce on Electroconvulsive 
therapy (APA Taskforce on Electroconvulsive Therapy 
1978). While other work (Weiner, 1980; Delva et al., 2001) 
appears to support this quantum, a positive correlation be-
tween seizure duration has not been demonstrated (Andrade 
et al., 1988; Lalla and Milroy, 1996; Shapira et al., 1996; 
Abrams, 2002). 
 
Abrams (2002) states that the recommended minimum sei-
zure duration of 25-30 seconds was arrived at “arbitrarily”, 
and “it might just as well have been 10 seconds or 60 sec-
onds”. 
While seizures of less than 25-30 seconds can be therapeutic, 
Krystal et al. (2000) have shown that patients experiencing 
seizures of < 25 seconds have a depression response rate of 
32%, and those experiencing seizures of > 25 seconds have a 
response rate of 66%. In a field of many uncertainties, such 
findings have clinicians favouring longer seizures. 
Stimulus dose and electrode position are complicating fac-
tors. Sackeim et al. (1987), for example, showed that seizures 
of greater than 25 seconds have little therapeutic effect in 
low dose, unilateral ECT. 
E
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Until recent decades, seizure duration was exclusively deter-
mined by the cessation of clonic movements. Some services 
use the “cuff method”, which attempts to prevent depolariz-
ing agent reaching the periphery of an upper limb, in the 
effort to better identify the end of the seizure. The Royal 
College of Psychiatrists’ Special Committee on ECT, how-
ever, described the cuff method as unreliable (Scott, 2005). 
EEG seizure description is beset by difficulties. “Seizure 
morphology” varies with ECT technique, for example, the 
“seizure intensity” of low dose unilateral ECT differs from 
that of high dose bilateral (Krystal et al., 1993) and EEG 
ictal features change over the course of treatment (Krystal et 
al., 1996). In short, physiological measurements (both EEG 
and ECG based) are yet to be universally approved and 
routinely applied in clinical practice. In fact, “The impor-
tance of seizure morphology in predicting clinical outcome is 
far from being understood” and “EEG seizures” are fre-
quently less useful than the observation of clonic move-
ments (McCall, 2009). 
A progressive decrease in seizure duration over the course of 
ECT has been reported (Holmberg, 1954; Small et al., 1981; 
Kales et al., 1997). Such seizure duration decrease has been 
linked to progressive threshold increase (Shapira et al., 1996; 
Abrams 2002). The notion that seizure duration decreases 
over the course of ECT helped shape the recommendation 
that compensatory increases in stimulus intensity be made 
(Swartz 1993 & 2002, Abrams 2002). Consistent with seizure 
duration decrease over the course of ECT are the observa-
tions of Abrams (2002), that the first seizures are always 
longest, of Glenisson et al. (1998), that most prolonged 
seizures occur during the first treatment of a series, and of 
van Waarde et al. (2010), that for people receiving continua-
tion ECT, increased time interval between treatment ses-
sions correlates with increased seizure duration. However, di 
Michele et al. (1992) using a fixed dose stimulus, and Scott 
and Boddy (2000) using stimulus dosing strategy, did not 
show a significant change in seizure duration over a course 
of treatment. 
Electrode placement has been found to influence seizure 
duration, significantly longer seizures being associated with 
bilateral compared to unilateral placement (Weiner, 1980). 
However, most reports (Weiner et al., 1986; Sackeim et al., 
1987; Delva et al., 2000) have found no difference in seizure 
duration between electrode placements, in low dose ECT. 
In general, stimulus intensity is positively associated with 
seizure duration (Azuma, 2009), and this has intuitive appeal. 
However, some evidence suggests that seizure duration is 
inversely related to stimulus intensity (Delva et al., 2000). 
Age has been known to be positively correlated with seizure 
threshold for over half a century (Watterson, 1945, Delva et 
al., 2000). Rasimas et al. (2007) reported a strong inverse 
correlation between age and seizure duration. Gender is a 
strong predictor of seizure threshold, males having higher 
thresholds (Sackeim et al., 1987; 1991). Rasimas et al. (2007) 
found that females have longer first seizures than males, but 
there was no gender influence on the duration of subsequent 
seizures. 
 
ECT practitioners may have concerns when seizures do not 
last 25–30 seconds, and when seizure duration does not 
reduce over the course of treatment. In this naturalistic study 
the aim was to examine the impact on seizure duration of 
stimulus intensity, previous treatments (during the first 
course of ECT), age, gender, and electrode placement. 
Method 
The Department of Psychological Medicine at the Royal 
Hobart Hospital is associated with the University of Tasma-
nia, Australia. The ECT Service of this department has gen-
erated half a dozen papers and letters over 15 years, but is 
not directly attached to the university and is not conducting 
ongoing research. It has a dedicated ECT nurse and the 
medical staff are credentialed to provide ECT by the hospi-
tal. The machines most recently deployed were Thymatron® 
DG (1993-2007) and Thymatron® System IV (2007-2010). 
The anaesthesia procedure for ECT at the RHH has not 
varied in the last 15 years and  includes pre-oxygenation, and 
the anaesthetic agents, atropine 0.4-0.8 mg, propofol 1-2 
mg/kg, and succinylcholine 0.5 mg/kg. 
Two electrode placements are used: bilateral (bitemporal) 
and unilateral (using the d’Elia positions). 
Three dosing methods have been used at different times and 
concurrently (different clinicians having different prefer-
ences): i) fixed-high-dose (> 453.6 mC or > 90% of machine 
output), applied either unilaterally or bilaterally, ii) age-based 
stimulation (the age of the individual determining the per-
centage of machine output, applied either unilaterally or 
bilaterally), and iii) stimulus titration (with treatment being 
applied at 2.5 X threshold stimulus, applied right unilater-
ally). 
The duration of the seizure is determined by observation of 
cessation of clonic movements in all body regions. Addi-
tional information regarding the adequacy/quality of the 
seizure is drawn from the EEG including EEG endpoint, 
average seizure energy index, postictal suppression index, 
maximum sustained power, maximum sustained coherence 
and time to peak coherence. As the machines frequently fail 
to calculate one or more of these quanta, they are not relied 
upon, and will not be considered in this report. 
The ECT Service (RHH) provides treatment comparable to 
that of many non-research ECT services of other major 
Australian hospitals.  
Records were examined for the 15 year period ending in mid 
2010, and 921 first courses of ECT were located. Courses 
were selected for inclusion when, 1) there had been no 
change in the stimulus dose during the course, and 2) at least 
5 treatments had been provided. Seizure duration was exam-
ined for the first 5 or 6 seizures. 
It was not possible to ascertain comprehensive details of 
medication. The great majority were taking an antidepres-
sant, antipsychotic or mood stabilizer, or a combination of 
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these. Benzodiazepines are used sparingly at the Royal 
Hobart Hospital, and these are reduced or ceased when ECT 
is to be provided, but a small proportion of patients selected 
for examination would have been receiving benzodiazepines 
and/or an anticonvulsant. 
Statistical Analysis 
A standard multiple linear regression was performed taking 
seizure duration as the criterion and the following variables 
as predictors: stimulus intensity, age, number of previous 
session (course), and unilateral/bilateral application. Prior to 
interpreting the results of the multiple regression, the as-
sumptions of normality, linearity, and homoscedasticity of 
residuals were tested. In addition, multivariate outliers were 
assessed with Mahalanobis distance.  
Results 
Records were located of 383 patients who received an aver-
age of 5.3 ECT treatments, making a total of 2023 treat-
ments. These were 164 males and 219 females, with a mean 
age of 48.03 (SD=15.87) years. 193 patients received unilat-
eral treatment and 190 received bilateral. The mean seizure 
duration was 23.99 (SD=9.99) sec. 
The multiple linear regression was used to investigate each 
of the predictors (stimulus intensity, age, number of previous 
session (course), and unilateral/bilateral application) contri-
butions to the seizure length. Homoscedasticity was exam-
ined via several scatterplots and these indicated reasonable 
consistency of spread through the distributions. Mahalanobis 
distance did not exceed the critical χ2 for df=4(at α=.001) of 
18.47 for any case in the data, indicating that multivariate 
outliers were not of concern. Correlations between stimulus 
intensity, age, number of previous session were small (range 
between -.133 and .210), indicating multicollinearity is 
unlikely to be a problem.  
Since no a priori hypotheses had been made to determine the 
order of entry of the predictor variables, a direct method was 
used for the multiple linear regression analyses.  The four 
predictors produced an adjusted R2 of .112 (F (4,378) = 
11.84, p <.001) for the prediction of seizure length. How-
ever, the stimulus intensity was the only predictor which 
showed significant regression coefficient (see Table 1). 
 
Table 1. Standard Regression Coefficients (β), and 
Squared Semi-Partial Correlations (sr2) for Each 
Predictors in a Linear Regression Model Predicting 
Seizure Length 
Variable β p sr2 
Age -.060 .235 .003 
Stimulus Intensity -.267 .001 .042 
Number of pre-
vious sessions 
-.048 .333 .002 
Uunilateral/  
bilateral 
.062 .322 .002 
Discussion 
This study is limited by 1) the retrospective design, and 2) 
involving patients taking psychotropic medication. This is a 
large (in terms of both time period and numbers treated) 
naturalistic study. Such studies carry the disadvantage of 
retrospection, but the advantage of being closer to the cir-
cumstances encountered in ordinary clinical practice. For 
example, in this study patients continued on at least some 
psychotropic medication, which is the routine practice in 
many service orientated units, but eschewed in research 
centres. 
A further criticism of the study can be that we used propo-
fol, which is known to reduce seizure duration (Fredman et 
al., 1994). Tan & Lee, (2009) found seizures associated with 
propofol to be half the length of those associated with 
etomidate. However, propofol was used for every ECT, and 
while the use of this agent may explain some overall seizure 
brevity, it would not explain the important findings of this 
study (that very high stimulus intensity shortens seizure 
duration and that during a course of ECT, seizure duration 
remains relatively constant). 
We were inspired to conduct this study by years of providing 
ECT equipped with limited useful information on seizure 
duration. There is no universally agreed objective monitoring 
technique to determine seizure duration. Further, it is com-
mon for the device one is reliant upon to fail to provide one 
or many of those “Seizure Quality Measures” which are 
purported to possess some value in seizure monitoring. 
Thus, the clinician is often left largely reliant on the observa-
tion of the clonic movements to make the seizure duration 
determinations. 
Clinical experience and some authorities (Abrams 2002; 
Scott, 2005) inform that seizures of less than 25-30 seconds 
can be therapeutic. However, there is a large body of infor-
mation (Krystal et al., 2000) indicating that the chances of a 
therapeutic outcome are greater when the seizure length is at 
least this long. There is evidence to suggest that seizure 
duration decreases over the course (Holmberg, 1954; Small 
et al., 1981); Kales et al. (1997) reported a 37% duration 
reduction. Duration reduction is consistent with the anticon-
vulsant hypothesis of ECT, which is based on the observa-
tion that seizure threshold increases over the course of ECT 
(Sackeim et al., 1987). Thus, in ordinary ECT practice there 
may be concern when the seizure duration is less than 25 
seconds and the duration of the seizure does not decrease. 
The advantage of this study is that it is large, drawn from a 
period of 15 years and identified 383 first courses of ECT in 
which at least 5 treatments having been provided, and with 
the same anaesthetic applied in every case. 
It is also important because 64% of patients (246) received 
fixed high dose stimulation. We had been influenced by 
Abrams (1992) who recommended “375 to 500 mC” (ap-
proximately 75-100% of machine output) applied right uni-
laterally. 
The multiple linear regression analysis suggested that the 
effects of age, number of previous session, and electrode 
PRIDMORE ET AL. 
 38 
position (bilateral and unilateral) on the seizure length were 
rather negligible. Only the effect of stimulus intensity was 
significant, indicating that higher the stimulus intensity, 
shorter the seizure durations. 
This is counter intuitive, one might expect that stronger 
stimulation would result in longer seizure, however, Delva et 
al. (2000) has reported seizure duration being inversely re-
lated to the applied charge. This observation may be related 
to the observations that higher doses (at least to some de-
gree) are associated with better therapeutic outcomes 
(Sackeim et al., 1987), and the degree of post ictal suppres-
sion is related to clinical improvement of depression (Nobler 
et al., 1993). However, to our knowledge, any relationship 
between duration and post-ictal suppression is yet to be fully 
explored. 
This study looks at seizure duration independent of thera-
peutic outcome. It confirms that seizure duration does not 
inevitably shorten with the progression of therapy. In addi-
tion, if fixed high dose ECT is being provided, and there is 
concern due to the brevity of seizures, rather than taking 
steps to increase the output of the machine, a modest reduc-
tion of dose (perhaps to < 428.4 mC, or < 85% of machine 
output) may increase seizure duration. 
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